阿卡迈科技 AKAM 深 沪
等待开盘 02-02 09:30:00 美东时间
97.15
-2.200
-2.21%
华盛通- 最 高99.25
- 今 开98.73
- 成交量 298.38万股
- 最 低 95.935
- 昨 收 99.35
- 总市值 139.90亿
- 52周最高 104.975
- 市盈率 静 29.70
- 换手率 2.07%
- 52周最低 67.51
- 委 比 -87.66%
- 总股本 1.44亿
- 历史最高 129.17
- 量 比 0.64
- 振 幅 3.34%
- 历史最低 18.25
- 每 手 1
- 风险率 7.56%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Akamai Is Recognized as a 2026 Gartner® Peer Insights™ Customers’ Choice for Network Security Microsegmentation
Akamai Technologies has been named a Gartner Peer Insights Customers' Choice in Network Security Microsegmentation for January 2026, achieving a 99% recommendation rate. This recognition highlights Akamai's strong customer focus and user experience. Network security microsegmentation enables dynamic access policies across cloud environments, essential for modern security strategies. Akamai's solutions received high praise from customers across in...
01-27 18:00
Akamai CTO Robert Blumofe Reports Disposal of Common Shares
Akamai CTO Robert Blumofe Reports Disposal of Common Shares Robert Blumofe, Chief Technology Officer of Akamai Technologies Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologie
01-24 05:59
Deutsche Telekom Security Expands Cybersecurity Offerings with Akamai
Deutsche Telekom Security is using Akamai's Security Certified Service Provider programs to enhance its cybersecurity services, offering proactive API security, microsegmentation, and compliance support for industries like finance and critical infrastructure. The partnership provides services such as API lifecycle management, hybrid deployments, and specialized segmentation support, all while ensuring regulatory compliance. With Akamai's help, De...
01-21 06:30
美股大行评级 | 潜在上涨空间31.6%！巴克莱上调台积电目标价至450美元；第一地平线全国银行获5家机构上调目标价
今日重点评级关注：Guggenheim：维持MBX Biosciences"买入"评级，目标价从77美元升至88美元；摩根士丹利：维持DraftKings"超配"评级，目标价从50美元升至53美元
01-20 10:26
Citigroup Maintains Neutral on Akamai Technologies, Raises Price Target to $103
Citigroup analyst Fatima Boolani maintains Akamai Technologies (NASDAQ:AKAM) with a Neutral and raises the price target from $88 to $103.
01-17 02:36
美股大行评级 | Medline获14家大行首予评级，最高目标价52美元；富国银行上调GOOGL目标价从268美元升至350美元
今日重点评级关注：HC Wainwright & Co.：维持Enlivex Therapeutics"买入"评级，目标价从7美元升至13美元；BTIG：维持Oruka Therapeutics"买入"评级，目标价从63美元升至73美元
01-13 10:18
Applied Materials To Rally Around 33%? Here Are 10 Top Analyst Forecasts For Monday
Top Wall Street analysts changed their outlook on these top names. For a comple...
01-12 22:26
Biggest stock movers Monday: Credit card firms, SNCY, WMT and more
U.S. equity futures eased on Monday after Federal Reserve Chair Jerome Powell revealed that the Justice Department had issued grand jury subpoenas to the central bank, raising the prospect of a crimin...
01-12 17:37
美股大行评级 | 瑞穗上调英伟达、谷歌、美光科技、SanDisk多家科技股目标价；中金首予诺和诺德"跑赢大市"评级，目标价73.5美元
今日重点评级关注：Needham：维持Cartesian Therapeutics"买入"评级，目标价从40美元升至42美元；Piper Sandler：维持Acrivon Therapeutics"超配"评级，目标价从6美元升至8美元
01-12 14:09
美股大行评级 | 潜在涨幅36.7%！LMRI获多家大行首予超配评级； 瑞银下调甲骨文目标价从325美元至280美元
今日重点评级关注：HC Wainwright & Co.：维持Assertio Holdings"买入"评级，目标价从3美元升至35美元；HC Wainwright & Co.：维持万达生物制药"买入"评级，目标价从20美元升至22美元
01-06 17:52
